[{"address1": "1200 Brickell Avenue", "address2": "Suite 1950 #1183", "city": "Miami", "state": "FL", "zip": "32183", "country": "United States", "phone": "786-432-9792", "website": "https://mirapharmaceuticals.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Erez  Aminov", "age": 46, "title": "CEO & Chairman", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 626193, "exercisedValue": 0, "unexercisedValue": 113700}, {"maxAge": 1, "name": "Mr. Alan  Weichselbaum CPA, M.B.A.", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Itzchak  Angel Ph.D.", "title": "Chief Scientific Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.44, "open": 1.43, "dayLow": 1.4, "dayHigh": 1.4795, "regularMarketPreviousClose": 1.44, "regularMarketOpen": 1.43, "regularMarketDayLow": 1.4, "regularMarketDayHigh": 1.4795, "payoutRatio": 0.0, "beta": 1.749, "forwardPE": -2.9795918, "volume": 308441, "regularMarketVolume": 308441, "averageVolume": 3179801, "averageVolume10days": 571690, "averageDailyVolume10Day": 571690, "bid": 1.43, "ask": 1.49, "bidSize": 4, "askSize": 4, "marketCap": 30397662, "fiftyTwoWeekLow": 0.73, "fiftyTwoWeekHigh": 2.45, "allTimeHigh": 7.98, "allTimeLow": 0.51, "fiftyDayAverage": 1.4291, "twoHundredDayAverage": 1.283265, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 27110724, "profitMargins": 0.0, "floatShares": 12720377, "sharesOutstanding": 20820315, "sharesShort": 277187, "sharesShortPriorMonth": 194669, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0145000005, "heldPercentInsiders": 0.36569, "heldPercentInstitutions": 0.05692, "shortRatio": 0.1, "shortPercentOfFloat": 0.0196, "impliedSharesOutstanding": 20820315, "bookValue": 0.033, "priceToBook": 44.242424, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -7765054, "trailingEps": -0.47, "forwardEps": -0.49, "52WeekChange": -0.15789473, "SandP52WeekChange": 0.1198014, "quoteType": "EQUITY", "currentPrice": 1.46, "targetHighPrice": 17.75, "targetLowPrice": 3.0, "targetMeanPrice": 10.375, "targetMedianPrice": 10.375, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 730475, "totalCashPerShare": 0.038, "totalDebt": 0, "quickRatio": 2.447, "currentRatio": 2.791, "returnOnAssets": -2.53313, "returnOnEquity": -5.5686903, "freeCashflow": -3230965, "operatingCashflow": -6076819, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MIRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "priceEpsCurrentYear": -4.866667, "fiftyDayAverageChange": 0.030900002, "fiftyDayAverageChangePercent": 0.021622, "twoHundredDayAverageChange": 0.17673504, "twoHundredDayAverageChangePercent": 0.13772295, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-08-03", "cryptoTradeable": false, "postMarketTime": 1762561441, "regularMarketTime": 1762549202, "exchange": "NCM", "messageBoardId": "finmb_1793899557", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "MIRA Pharmaceuticals, Inc.", "longName": "MIRA Pharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1691069400000, "postMarketChangePercent": -0.6917813, "postMarketPrice": 1.4499, "postMarketChange": -0.010100007, "regularMarketChange": 0.02, "regularMarketDayRange": "1.4 - 1.4795", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 3179801, "fiftyTwoWeekLowChange": 0.73, "fiftyTwoWeekLowChangePercent": 1.0, "fiftyTwoWeekRange": "0.73 - 2.45", "fiftyTwoWeekHighChange": -0.99, "fiftyTwoWeekHighChangePercent": -0.40408164, "fiftyTwoWeekChangePercent": -15.789473, "epsTrailingTwelveMonths": -0.47, "epsForward": -0.49, "epsCurrentYear": -0.3, "corporateActions": [], "regularMarketChangePercent": 1.38889, "regularMarketPrice": 1.46, "displayName": "MIRA Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]